scholarly article | Q13442814 |
P356 | DOI | 10.1016/0042-6822(92)91251-O |
P698 | PubMed publication ID | 1382345 |
P2093 | author name string | R. Schlegel | |
A. B. Jenson | |||
S. J. Ghim | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virion | Q1757347 |
P304 | page(s) | 548-552 | |
P577 | publication date | 1992-09-01 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions | |
P478 | volume | 190 |
Q52508932 | A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles |
Q37830705 | Advances in human papilloma virus vaccines: a patent review |
Q40129444 | Anti-Infectious Human Vaccination in Historical Perspective |
Q37307576 | Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer. |
Q40533813 | Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells |
Q35595612 | Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein. |
Q35131073 | Development of a 2-plex luminex-based competitive immunoassay to quantify neutralizing antibodies induced by virus-like particles for human papillomavirus 16 and 18. |
Q45334982 | Factors influencing the willingness of US women to vaccinate their daughters against the human papillomavirus to prevent cervical cancer |
Q64377560 | HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice |
Q35235035 | How will HPV vaccines affect cervical cancer? |
Q24645760 | Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts |
Q43187047 | Human papillomavirus infection |
Q26853556 | Human papillomavirus vaccination: a case study in translational science |
Q34708041 | Prevention of cancer through immunization: Prospects and challenges for the 21st century. |
Q35919119 | Progress in the development of a cervical cancer vaccine. |
Q90079811 | Public-private knowledge transfer and access to medicines: a systematic review and qualitative study of perceptions and roles of scientists involved in HPV vaccine research |
Q37488845 | Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer |
Q36102960 | Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves |
Q33707499 | Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas |
Q24610004 | The history of tumor virology |
Q33932258 | Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit |
Search more.